Masanao Hirai
Jikei University School of Medicine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Masanao Hirai.
Perspectives in Biology and Medicine | 1968
Masanao Hirai; Yoshiko Morita; Takeshi Nakao
France and Pincus [i] reported that administration of I7a-ethynyl5(io)-estrene-i7/3-ol-3-one (norethynodrel) resulted in the inhibition of gonadotropin-induced ovulation, as determined by the significant decrease in the mean number of ova recovered from the fallopian tubes of rats, and ovarian weight was decreased in hypophysectomized, gonadotropin-primed rats treated with norethynodrel suggesting a direct inhibitory action on the follicular growth induced by exogenous gonadotropins. Since Zanders observation [2-4], workers have demonstrated the presence of 4-pregnen-2oa-ol-3-one (2Oa-OH-P) in different species [5-7]. Recently, Hilliard, Penardi, and Sawyer [8] suggested that this 2Oa-OH-P acts as a positive feedback agent to prolong and heighten LH discharge in the mated rabbit. The secretion of progesterone by ovarian corpora lutea and the essential role of this steroid in implantation and maintenance of fertilized ova have been well established. In addition to this progestogen, the mammarian ovary synthesizes and releases two structurally similar compounds, 2Oa-OH-P and/or its 0-isomer (20/3-OH-P), to which no specific physiological functions have yet been assigned. The present experiments were carried out to define the effect of norethynodrel on ovulation and to determine whether the norethynodreltreated rat would have altered progestins in ovarian venous blood and the ovaries in vivo.
Perspectives in Biology and Medicine | 1968
Masanao Hirai; Yoshiko Morita; Takeshi Nakao
Ovulation can be inhibited by both progesterone and testosterone, but certain newer synthetic compounds related to these are extremely effective and produce fewer undesirable side effects. Among these are: norethindrone, which is also classified as a 19-nortestosterone, and norethynodrel, which is more closely related to the estrogens. Fairly large scale studies in Puerto Rico [1] and Haiti [2] have revealed that these compounds when taken by mouth prevent ovulation, and therefore conception, in a very high proportion of sexually active women. Field trials of these and similar oral contraceptive substances are currently proceeding in a number ofheavily populated parts of the world, and they are being watched with interest by all those who are concerned with the problems raised by our worldwide population explosion. Biochemical control of contraception as most widely practiced is attained by means of the orally active ovulation inhibitors. The problem of the mechanisms of action of the synthetic progestins has been extensively discussed in numerous publications [3]. However, fundamental significance of norethynodrel as ovulation inhibitor remains unknown. In rabbits the steroidogenic response of the ovaries to LH, mating, or electrical stimulation of the hypothalamus or medial amygdala [4] is extremely rapid and appears to have a lower threshold than the ovulatory response [5]. The marked stimulus by FSH of follicle growth seen in * A preliminary report of this paper was presented at the 3d Asian and Oceanic Congress ofEndocrinology at Manila, January, 1967. t Department of Pharmacology, Jikei University School of Medicine, Tokyo, Japan. We are grateful to: Yoshiko Masubuchi for technical assistance; Dr. Gregory Pincus for his advice and for a gift of 4-pregnen-2oa-ol-3-one; Drs. Yoshihito Omori and Sumio Shima for infrared spectra analysis; and Dr. Tomojy Yanagita, Central Laboratory for Experimental Animals, Tokyo, for the Sprague-Dawley rats.
European Journal of Endocrinology | 1982
Yoshiko Masubuchi; Toshio Kumai; Akiyo Uematsu; Kenji Komoriyama; Masanao Hirai
European Journal of Endocrinology | 1979
Sumio Shima; Yoshiko Kawashima; Masanao Hirai
Endocrinologia Japonica | 1970
Masanao Hirai; Lin Kae Nan; Takeshi Nakao
Journal of Toxicological Sciences | 1992
Yoshiko Masubuchi; Mari Akaike; Toshio Kumai; Masami Tanaka; Minoru Watanabe; Masanao Hirai
Folia Pharmacologica Japonica | 1991
Yoshiko Masubuchi; Toshio Kumai; Masami Tanaka; Minoru Watanabe; Mari Akaike; Masanao Hirai
Folia Pharmacologica Japonica | 1981
Masanao Hirai; Yoshiko Masubuchi; Toshio Kumai; Uematsu A; Komoriyama K
Endocrinologia Japonica | 1971
Masanao Hirai; Yoshiko Masubuchi; Takeshi Nakao
Journal of Toxicological Sciences | 1994
Satoru Oneda; Hidenobu Sameshima; Takashi Yamamoto; Kouichi Fukuda; Toshio Ihara; Yoshiko Masubuti; Masanao Hirai; Ryoichi Nagata